ANIDO ARMANDO
CIK: 0001219866•Chairman & Chief Exec. Officer
OfficerDirector
Primary company: AUXILIUM PHARMACEUTICALS INC (AUXL)
ANIDO ARMANDO is a corporate insider (Chairman & Chief Exec. Officer) at AUXILIUM PHARMACEUTICALS INC (AUXL) filing SEC Form 4 transactions. 159 transactions across 7 companies, totaling $219,188 in purchases and $5,559,931 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
SCYNEXIS INC SCYX | Award | 2,875 | $3.85 | $11K | 2,875 | 6/26/2026 Filed: 6/26/2026 | Filing → |
SCYNEXIS INC SCYX | Award | 2,875 | - | - | 11,750 | 6/26/2026 Filed: 6/26/2026 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 23,000 | 6/26/2025 Filed: 6/30/2025 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 71,000 | 6/26/2025 Filed: 6/30/2025 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 23,000 | 6/20/2024 Filed: 6/21/2024 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 48,000 | 6/20/2024 Filed: 6/21/2024 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Disposition | 190,000 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 13,297 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 26,595 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 610,000 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 240,000 | - | - | 610,000 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 566,722 | - | - | 370,000 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Sale | 17,830 | $1.33 | $24K | 936,722 | 9/13/2023 Filed: 9/14/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 64,747 | - | - | 954,552 | 9/12/2023 Filed: 9/14/2023 | Filing → |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 25,000 | 6/15/2023 Filed: 6/23/2023 | Filing → |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 10,000 | 6/15/2023 Filed: 6/20/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Tax Payment | 12,547 | $0.60 | $7K | 889,805 | 2/8/2023 Filed: 2/9/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 45,406 | - | - | 902,352 | 2/7/2023 Filed: 2/9/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Tax Payment | 11,726 | $0.60 | $7K | 856,946 | 2/1/2023 Filed: 2/2/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 42,437 | - | - | 868,672 | 1/31/2023 Filed: 2/2/2023 | Filing → |
SCYNEXIS INC
SCYX
Type
Award
Shares
2,875
Price
$3.85
Value
$11K
SCYNEXIS INC
SCYX
Type
Award
Shares
2,875
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Disposition
Shares
190,000
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
13,297
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
26,595
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
610,000
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
240,000
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
566,722
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Sale
Shares
17,830
Price
$1.33
Value
$24K
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
64,747
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Tax Payment
Shares
12,547
Price
$0.60
Value
$7K
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
45,406
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Tax Payment
Shares
11,726
Price
$0.60
Value
$7K
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
42,437
Price
-
Value
-
AI Agent
Try asking...